Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia

Morgan Anderson, Jason Powell, Kendall M. Campbell, James R. Taylor

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


With the number of individuals diagnosed with type 2 diabetes on the rise, it has become more important to ensure these patients are effectively treated. The Centers for Disease Control and Prevention estimated that 8.3% of all Americans were diagnosed with diabetes in 2011 and this number will likely continue to rise. With lifestyle interventions, such as proper diet and exercise, continuing to be an essential component of diabetes treatment, more patients are requiring medication therapy to help them reach their therapeutic goals. It is important for the clinician, when determining the treatment strategy for these individuals, to find a balance between reaching treatment goals and limiting the adverse effects of the treatments themselves. Of all the adverse events associated with treatment of diabetes, the risk of hypoglycemia is one that most therapies have in common. This risk is often a limiting factor when attempting to aggressively treat diabetic patients. This manuscript will review how hypoglycemia is defined and categorized, as well as discuss the prevalence of hypoglycemia among the many different treatment options.

Original languageEnglish (US)
Pages (from-to)85-94
Number of pages10
JournalDiabetes, Metabolic Syndrome and Obesity
StatePublished - Mar 6 2014
Externally publishedYes


  • Hypoglycemia
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Pharmacology


Dive into the research topics of 'Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia'. Together they form a unique fingerprint.

Cite this